Abeona Therapeutics CEO Michael Amoroso's 2021 pay jumps 104% to $3.1M
Abeona Therapeutics reports 2021 executive compensation
By ExecPay News
Published: July 11, 2022
Abeona Therapeutics reported fiscal year 2021 executive compensation information on July 11, 2022.
In 2021, four executives at Abeona Therapeutics received on average a compensation package of $1.8M, a 52% increase compared to previous year.
Average pay of disclosed executives at Abeona Therapeutics
Michael Amoroso, Chief Executive Officer, received $3.1M in total, which increased by 104% compared to 2020. 52% of Amoroso's compensation, or $1.6M, was in option awards. Amoroso also received $450K in salary, $1M in stock awards, as well as $12K in other compensation.
Edward Carr, Chief Financial Officer, received a compensation package of $1.6M, which increased by 70% compared to previous year. 40% of the compensation package, or $634K, was in option awards.
Vishwas Seshadri, Chief Executive Officer, earned $1.6M in 2021.
Brendan O'Malley, General Counsel, received $1.2M in 2021.
Related executives
You may also like
Source: SEC filing on July 11, 2022.